ASX ANNOUNCEMENT Invion Limited ABN 76 094 730 417 Suite 2, Level 11, 385 Bourke Street Melbourne, VIC 3000 P: +61 3 9692 7222 W: www.inviongroup.com CREDENTIALED INTERNATIONAL BIOTECH LEADER JOINS INVION’S BOARD MELBOURNE (AUSTRALIA) 19 August 2026: Invion...
IVX Credentialed International Biotech Leader Joins Board
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Appendix 4C and Quarterly Activities Report - June 2026
- Photosoft Platform Expands to Eye Diseases Via Partnership
- Appendix 4C and Quarterly Activities Report - March 2026
- Skin Cancer Trial Moves to BCC With More Encouraging Signals
- Appendix 4D and Half Year Financial Report
Later from Invion
- Final Director's Interest Notice - Alistair Bennallack
- Initial Director's Interest Notice - Paul FIeld
- Appendix 4E and Annual Report
- Appendix 4G and Corporate Governance Statement
- Director Loans
Follow Invion into a list and get an email when it puts out news.
Follow Invion